Established in 1997 and based in Berlin, Germany, MagForce AG specializes in... Established in 1997 and based in Berlin, Germany, MagForce AG specializes in developing and delivering nanotechnology-driven cancer treatments. The company's operations are primarily concentrated in Germany and Poland. Their core offerings include NanoTherm, a therapeutic solution specifically designed for addressing brain tumors. Complementing this therapy, they also provide NanoPlan, an advanced software tool that assists medical professionals in meticulously crafting optimal treatment strategies for NanoTherm, along with the NanoActivator, a specialized magnetic field generator integral to the treatment process.
